163 related articles for article (PubMed ID: 31192127)
1. Aurora-A Induces Chemoresistance Through Activation of the AKT/mTOR Pathway in Endometrial Cancer.
Wu J; Cheng Z; Xu X; Fu J; Wang K; Liu T; Wu C; Kong X; Yang Q; Yan G; Zhou H
Front Oncol; 2019; 9():422. PubMed ID: 31192127
[TBL] [Abstract][Full Text] [Related]
2. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells.
Yang H; He L; Kruk P; Nicosia SV; Cheng JQ
Int J Cancer; 2006 Nov; 119(10):2304-12. PubMed ID: 16894566
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
4. Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways.
Li Y; Zhou W; Tang K; Chen X; Feng Z; Chen J
Oncol Rep; 2017 Oct; 38(4):2011-2022. PubMed ID: 28849180
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway.
Lin Q; Wang Y; Chen D; Sheng X; Liu J; Xiong H
Oncol Lett; 2017 May; 13(5):3567-3571. PubMed ID: 28521459
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells.
Li J; Sun H; Liu T; Kong J
Exp Ther Med; 2018 Nov; 16(5):4213-4224. PubMed ID: 30344696
[TBL] [Abstract][Full Text] [Related]
8. Chronic BDE-47 Exposure Aggravates Malignant Phenotypes and Chemoresistance by Activating ERK Through ERĪ± and GPR30 in Endometrial Carcinoma.
Zhang F; Peng L; Huang Y; Lin X; Zhou L; Chen J
Front Oncol; 2019; 9():1079. PubMed ID: 31737560
[TBL] [Abstract][Full Text] [Related]
9. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
11. CD47 Enhances Cell Viability and Migration Ability but Inhibits Apoptosis in Endometrial Carcinoma Cells via the PI3K/Akt/mTOR Signaling Pathway.
Liu Y; Chang Y; He X; Cai Y; Jiang H; Jia R; Leng J
Front Oncol; 2020; 10():1525. PubMed ID: 32984001
[No Abstract] [Full Text] [Related]
12. Quinacrine in endometrial cancer: Repurposing an old antimalarial drug.
Kalogera E; Roy D; Khurana A; Mondal S; Weaver AL; He X; Dowdy SC; Shridhar V
Gynecol Oncol; 2017 Jul; 146(1):187-195. PubMed ID: 28545688
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.
Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P
J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026
[TBL] [Abstract][Full Text] [Related]
14. SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line.
Zhang Y; Jiang F; Bao W; Zhang H; He X; Wang H; Wan X
Cancer Cell Int; 2016; 16():29. PubMed ID: 27065754
[TBL] [Abstract][Full Text] [Related]
15. PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy.
Liu H; Zhang L; Zhang X; Cui Z
Onco Targets Ther; 2017; 10():2865-2871. PubMed ID: 28652768
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
17. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
[TBL] [Abstract][Full Text] [Related]
19. Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer.
Umene K; Yanokura M; Banno K; Irie H; Adachi M; Iida M; Nakamura K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Int J Oncol; 2015 Apr; 46(4):1498-506. PubMed ID: 25625960
[TBL] [Abstract][Full Text] [Related]
20. A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.
Li Y; Zhang Z; Zhang X; Lin Y; Luo T; Xiao Z; Zhou Q
Am J Transl Res; 2016; 8(2):719-31. PubMed ID: 27158364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
